314 Likes Disposals of own shares Brussels (Belgium), 17 July 2020 ¨C 20:00 (CEST) ¨C regulated information In accordance with article 8:6 of the Royal Decree executing the Belgian Code of Companies and Associations, ½ðºÌÓéÀÖ³Ç announces that, following exercises of stock options by members of its personnel, it has disposed of ½ðºÌÓéÀÖ³Ç shares OTC in view of deliveries of these shares to the relevant members of the personnel, within the framework of the Long Term Incentive Program of the ½ðºÌÓéÀÖ³Ç Group, as follows: This press release is available on ½ðºÌÓéÀÖ³Ç SA/NV¡¯s website via the following link. Investor Relations Antje Witte Investor Relations, ½ðºÌÓéÀÖ³Ç T +32.2.559.94.14 antje.witte@ucb.com Isabelle Ghellynck, Investor Relations, ½ðºÌÓéÀÖ³Ç T+32.2.559.9588, isabelle.ghellynck@ucb.com About ½ðºÌÓéÀÖ³Ç ½ðºÌÓéÀÖ³Ç, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With 7 500 people in approximately 40 countries, the company generated revenue of € 4.9 billion in 2019. ½ðºÌÓéÀÖ³Ç is listed on Euronext Brussels (symbol: ½ðºÌÓéÀÖ³Ç). Follow us on Twitter: @½ðºÌÓéÀÖ³Ç_news Asset Download 200717 - ½ðºÌÓéÀÖ³Ç Disposals of own shares 200717 - Ali¨¦nation d actions propres 200717 - Vervreemding van eigen aandelen 314 Likes
